As this process is triggered by the alteration of the mitophagic pathway and by the subsequent accumulation of damaged mitochondria [44], its activation should be evaluated in ALS patients with optineurin (OPTN) mutations. Here, OPTN is linked to amyotrophic lateral sclerosis.